ArticleOncoimmunology2025

The combination of body mass index and serum creatinine levels predicts survival in patients with Hodgkin lymphoma treated with nivolumab in the CheckMate 205 study.

Rosaria De Filippi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.